These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

506 related items for PubMed ID: 3514155

  • 1. A comparison of clobetasol propionate 0.05 percent ointment and an optimized betamethasone dipropionate 0.05 percent ointment in the treatment of psoriasis.
    Jacobson C, Cornell RC, Savin RC.
    Cutis; 1986 Mar; 37(3):213-4, 216, 218-20. PubMed ID: 3514155
    [Abstract] [Full Text] [Related]

  • 2. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis.
    Austad J, Bjerke JR, Gjertsen BT, Helland S, Livden JK, Morken T, Mørk NJ.
    J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):19-24. PubMed ID: 9731961
    [Abstract] [Full Text] [Related]

  • 3. A double-blind, multicenter comparison between 0.05% halobetasol propionate ointment and 0.05% betamethasone dipropionate ointment in chronic plaque psoriasis.
    Mensing H, Korsukewitz G, Yawalkar S.
    J Am Acad Dermatol; 1991 Dec; 25(6 Pt 2):1149-52. PubMed ID: 1757606
    [Abstract] [Full Text] [Related]

  • 4. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.
    Menter A, Abramovits W, Colón LE, Johnson LA, Gottschalk RW.
    J Drugs Dermatol; 2009 Jan; 8(1):52-7. PubMed ID: 19180896
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of twice-daily augmented betamethasone dipropionate lotion versus clobetasol propionate solution in patients with moderate-to-severe scalp psoriasis.
    Katz HI, Lindholm JS, Weiss JS, Shavin JS, Morman M, Bressinck R, Cornell R, Pariser DM, Pariser RJ, Weng W.
    Clin Ther; 1995 Jan; 17(3):390-401. PubMed ID: 7585843
    [Abstract] [Full Text] [Related]

  • 6. Efficacy, safety, and cost-effectiveness of all-trans retinoic acid/Clobetasol Propionate Compound Ointment in the treatment of mild to moderate psoriasis vulgaris: A randomized, single-blind, multicenter clinical trial.
    Xia L, Li R, Wang Y, Lin Z, Zheng J, Li X, Lu Q, Zhang J, Jin H, Fu L, Zhang X, Liu Y, Yang S, Xiao F, Gao XH.
    Dermatol Ther; 2018 Sep; 31(5):e12632. PubMed ID: 30253049
    [Abstract] [Full Text] [Related]

  • 7. Impact of clobetasol propionate 0.05% spray on health-related quality of life in patients with plaque psoriasis.
    Menter MA, Caveney SW, Gottschalk RW.
    J Drugs Dermatol; 2012 Nov; 11(11):1348-54. PubMed ID: 23135087
    [Abstract] [Full Text] [Related]

  • 8. Comparison of fluticasone propionate ointment, 0.005%, and betamethasone-17,21-dipropionate ointment, 0.05%, in the treatment of psoriasis.
    Roberts DT.
    Cutis; 1996 Feb; 57(2 Suppl):27-31. PubMed ID: 8646866
    [Abstract] [Full Text] [Related]

  • 9. Studies on the efficacy and adrenal effects of Diprolene ointment 0.05 percent and Dermovate ointment 0.05 percent in patients with psoriasis or other resistant dermatoses.
    Gip L, Hamfelt A.
    Cutis; 1984 Feb; 33(2):215-7, 220-2, 224. PubMed ID: 6365474
    [Abstract] [Full Text] [Related]

  • 10. Clobetasol propionate ointment 0.05% versus diflorasone diacetate ointment 0.05% in moderate to severe psoriasis.
    Jegasothy BV.
    Int J Dermatol; 1990 Dec; 29(10):729-30. PubMed ID: 2269571
    [No Abstract] [Full Text] [Related]

  • 11. The use of 0.25% zinc pyrithione spray does not enhance the efficacy of clobetasol propionate 0.05% foam in the treatment of psoriasis.
    Housman TS, Keil KA, Mellen BG, McCarty MA, Fleischer AB, Feldman SR.
    J Am Acad Dermatol; 2003 Jul; 49(1):79-82. PubMed ID: 12833013
    [Abstract] [Full Text] [Related]

  • 12. Clobetasol propionate 0.05% spray for the management of moderate-to-severe plaque psoriasis of the scalp: results from a randomized controlled trial.
    Sofen H, Hudson CP, Cook-Bolden FE, Preston N, Colón LE, Colón LE, Caveney SW, Gottschalk RW.
    J Drugs Dermatol; 2011 Aug; 10(8):885-92. PubMed ID: 21818510
    [Abstract] [Full Text] [Related]

  • 13. A double-blind comparison of quarter strength clobetasol propionate in Unguentum Merck with betamethasone valerate in psoriasis.
    Stankler L.
    Br J Clin Pract; 1983 Aug; 37(11-12):389-91. PubMed ID: 6367795
    [No Abstract] [Full Text] [Related]

  • 14. Clobetasol propionate ointment once daily versus fluocinonide ointment three times daily in psoriasis.
    Bickers D, Cornell R, Kamm AR, Bauman WE, Handler RM, Medansky RS, Sturm HM.
    Int J Dermatol; 1988 Aug; 27(1):54-5. PubMed ID: 3278991
    [No Abstract] [Full Text] [Related]

  • 15. Clobetasol propionate for psoriasis: are ointments really more potent?
    Warino L, Balkrishnan R, Feldman SR.
    J Drugs Dermatol; 2006 Jun; 5(6):527-32. PubMed ID: 16774104
    [Abstract] [Full Text] [Related]

  • 16. Intermittent topical treatment of psoriasis with betamethasone dipropionate 0.05 percent cream.
    van Dijk E, Bakkers EJ, Go MJ, Montnor LP, Roessel FE, van der Wateren AR, Wuite J.
    Cutis; 1983 Sep; 32(3):284-5, 287. PubMed ID: 6354613
    [Abstract] [Full Text] [Related]

  • 17. A randomized, double-blind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of nonscalp psoriasis.
    Lebwohl M, Sherer D, Washenik K, Krueger GG, Menter A, Koo J, Feldman SR.
    Int J Dermatol; 2002 May; 41(5):269-74. PubMed ID: 12100701
    [Abstract] [Full Text] [Related]

  • 18. Comparison of clobetasol propionate and betamethasone-17,21-dipropionate with reference to adrenal suppression.
    Eriksen K.
    Acta Derm Venereol; 1979 May; 59(4):372-4. PubMed ID: 92159
    [Abstract] [Full Text] [Related]

  • 19. Amcinonide vs. betamethasone dipropionate ointments in the treatment of psoriasis.
    Huntley AC, Isseroff R.
    Cutis; 1985 May; 35(5):489-92. PubMed ID: 3891239
    [Abstract] [Full Text] [Related]

  • 20. Diflorasone diacetate ointment 0.05% versus betamethasone dipropionate ointment 0.05% in moderate-severe plaque-type psoriasis.
    Shupack JL, Jondreau L, Kenny C, Stiller MJ.
    Dermatology; 1993 May; 186(2):129-32. PubMed ID: 8428041
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.